Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Scott Kinlay, Ph.D., M.B.,B.S.

Concepts

This page shows the publications Scott Kinlay has written about Coronary Disease.
Connection Strength

1.182
  1. Quality of life with PCI versus medical therapy in stable coronary disease. N Engl J Med. 2008 Nov 20; 359(21):2291; author reply 2292.
    View in: PubMed
    Score: 0.131
  2. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust. 2005 Jun 06; 182(11):597-8; author reply 598.
    View in: PubMed
    Score: 0.103
  3. Long-term effect of combined vitamins E and C on coronary and peripheral endothelial function. J Am Coll Cardiol. 2004 Feb 18; 43(4):629-34.
    View in: PubMed
    Score: 0.094
  4. Early statin therapy in acute coronary syndromes. Semin Vasc Med. 2003 Nov; 3(4):419-24.
    View in: PubMed
    Score: 0.092
  5. Early statin therapy in acute coronary syndromes. Minerva Cardioangiol. 2003 Oct; 51(5):577-84.
    View in: PubMed
    Score: 0.092
  6. Effects of statins on inflammation in patients with acute and chronic coronary syndromes. Am J Cardiol. 2003 Feb 20; 91(4A):9B-13B.
    View in: PubMed
    Score: 0.088
  7. Endothelial function and coronary artery disease. Curr Opin Lipidol. 2001 Aug; 12(4):383-9.
    View in: PubMed
    Score: 0.079
  8. Relation between endothelial dysfunction and the acute coronary syndrome: implications for therapy. Am J Cardiol. 2000 Oct 19; 86(8B):10J-13J; discussion 13J-14J.
    View in: PubMed
    Score: 0.075
  9. Inflammation, the endothelium, and the acute coronary syndromes. J Cardiovasc Pharmacol. 1998; 32 Suppl 3:S62-6.
    View in: PubMed
    Score: 0.062
  10. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol. 1997 Nov 06; 80(9A):11I-16I.
    View in: PubMed
    Score: 0.061
  11. Cost-effectiveness of coronary angioplasty versus medical treatment: the impact of cost-shifting. Aust N Z J Med. 1996 Feb; 26(1):20-6.
    View in: PubMed
    Score: 0.054
  12. The cost-effectiveness of different blood-cholesterol-lowering strategies in the prevention of coronary heart disease. Aust J Public Health. 1994 Mar; 18(1):105-10.
    View in: PubMed
    Score: 0.047
  13. A new method of estimating cost effectiveness of cholesterol reduction therapy for prevention of heart disease. Pharmacoeconomics. 1994 Mar; 5(3):238-48.
    View in: PubMed
    Score: 0.047
  14. The validity of estimating heart disease reduction from a Framingham logistic equation. J Clin Epidemiol. 1992 May; 45(5):553-60.
    View in: PubMed
    Score: 0.042
  15. Lipid and apolipoprotein levels in an Australian community. Med J Aust. 1991 Feb 04; 154(3):170-5.
    View in: PubMed
    Score: 0.038
  16. High cholesterol levels: is mass screening the best option? Med J Aust. 1988 Jun 20; 148(12):635-7.
    View in: PubMed
    Score: 0.032
  17. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities. J Lab Clin Med. 2001 Feb; 137(2):82-92.
    View in: PubMed
    Score: 0.019
  18. Cell dysfunction in atherosclerosis and the ischemic manifestations of coronary artery disease. Am J Cardiol. 1997 Mar 06; 79(5A):17-23.
    View in: PubMed
    Score: 0.015
  19. Reproducibility of coronary lumen, plaque, and vessel wall reconstruction and of endothelial shear stress measurements in vivo in humans. Catheter Cardiovasc Interv. 2003 Sep; 60(1):67-78.
    View in: PubMed
    Score: 0.006
  20. Lipid lowering improves endothelial functions. Int J Cardiol. 2000 Jun 30; 74 Suppl 1:S3-S10.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.